What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Robert Clarke mainly focuses on Internal medicine, Endocrinology, Genetics, Genome-wide association study and Breast cancer.
Robert Clarke interconnects Surgery and Cardiology in the investigation of issues within Internal medicine.
The various areas that he examines in his Endocrinology study include Estrogen receptor, Progesterone receptor and Mammary gland.
His studies deal with areas such as Coronary artery disease, Linkage disequilibrium, Genetic association, Heritability and Type 2 diabetes as well as Genome-wide association study.
His study in Breast cancer is interdisciplinary in nature, drawing from both Immunology, Cancer research, Signal transduction and Oncology.
His Stroke research is multidisciplinary, relying on both Disease, Cause of death and Regression dilution.
His most cited work include:
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. (7403 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Breast cancer, Cancer research, Endocrinology and Cancer.
His Internal medicine research includes themes of Oncology and Cardiology.
His Breast cancer study combines topics from a wide range of disciplines, such as Pathology, Surgical oncology, Immunology and Endocrine system.
His Cancer research research includes elements of Cancer cell, Cancer stem cell and Antiestrogen, Tamoxifen, Estrogen receptor.
His Cancer stem cell study is concerned with Stem cell in general.
Robert Clarke is involved in the study of Estrogen receptor that focuses on Estrogen receptor alpha in particular.
He most often published in these fields:
- Internal medicine (35.47%)
- Breast cancer (20.33%)
- Cancer research (18.83%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (35.47%)
- Cancer research (18.83%)
- Breast cancer (20.33%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cancer research, Breast cancer, Prospective cohort study and Cancer.
His Internal medicine research incorporates themes from Diabetes mellitus, Oncology and Cardiology.
His biological study spans a wide range of topics, including Cell, Cell growth, Cancer stem cell and Antiestrogen, Tamoxifen.
His Breast cancer research incorporates elements of Cancer cell, Metastasis, Estrogen and Endocrine system.
In his research, Obesity is intimately related to Body mass index, which falls under the overarching field of Prospective cohort study.
His Stroke study integrates concerns from other disciplines, such as Blood pressure, Disease and Myocardial infarction.
Between 2016 and 2021, his most popular works were:
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. (328 citations)
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. (328 citations)
- Association analyses based on false discovery rate implicate new loci for coronary artery disease. (313 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
The scientist’s investigation covers issues in Internal medicine, Stroke, Prospective cohort study, Cancer research and Odds ratio.
His research integrates issues of Gastroenterology, Mendelian randomization and Cardiology in his study of Internal medicine.
His work carried out in the field of Stroke brings together such families of science as Randomized controlled trial, Cause of death, Blood pressure, Myocardial infarction and Cohort.
His Prospective cohort study research is multidisciplinary, incorporating perspectives in Incidence, Diabetes mellitus, Demography, Proportional hazards model and Hazard ratio.
His studies examine the connections between Cancer research and genetics, as well as such issues in Breast cancer, with regards to Cancer cell and Estrogen.
His study on Odds ratio also encompasses disciplines like
- Type 2 diabetes and related Single-nucleotide polymorphism and Polymorphism,
- Heart disease and related PCSK9 and Cholesterol.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
